Chen Yuan-tsung, director of the Institute of Biomedical Sciences, Academia Sinica, says that what makes neonatal screening different from embryonic screening is that it aims to detect rare metabolic disorders that can be treated or prevented if they are discovered at an early stage. Infants are therefore given the chance to grow up healthy, or to suffer from fewer sequelae.
中研院生物醫學研究所所長陳垣崇指出，和胚胎篩檢不同的是，先天性代謝異常的疾病可以透過早期發現，給予適當的治療或預防，嬰兒即有機會正常成長，或將其後遺症減低。